Design and synthesis at University of Arizona
Researchers at the University of Arizona synthesized Melanotan II as a superpotent cyclic analog of α-MSH. The design incorporated cyclization and D-amino acid substitutions to increase receptor binding affinity and metabolic stability compared to the linear parent hormone.
Melanocortin receptor binding characterized
Studies documented that Melanotan II activates multiple melanocortin receptor subtypes, including MC1R (melanogenesis), MC3R, MC4R, and MC5R. This broad binding profile made it a valuable research tool for characterizing the melanocortin receptor family.
Human pigmentation studies
Clinical research documented dose-dependent increases in melanin production following subcutaneous administration in human subjects. These studies established quantitative dose-response relationships for melanocortin-induced melanogenesis.
MC4R-mediated effects discovered
Wessells et al. documented that Melanotan II produced physiological responses mediated through MC4R activation. This unexpected finding opened a new research direction and directly led to the development of PT-141 as a focused MC3R/MC4R agonist.
Int J Impot Res
Receptor selectivity research
Comparative studies examined Melanotan II's binding affinity across the melanocortin receptor family relative to endogenous ligands. Researchers documented its non-selective profile, activating MC1R through MC5R with varying affinities.
Historical milestones review published
Hadley and Dorr published a comprehensive review documenting the historical milestones of melanocortin peptide research, from the discovery of MSH through the development of Melanotan II and its derivatives. This review established the definitive historical record of the field.
Peptides
Pharmacokinetic characterization
Detailed pharmacokinetic studies examined absorption, distribution, and metabolism of Melanotan II, providing quantitative data on bioavailability and receptor occupancy that informed future melanocortin peptide design.
Melanocortin pathway research continues
Ongoing research continues to use Melanotan II as a reference compound for melanocortin receptor studies, including investigations into MC1R signaling, pigmentation biology, and appetite regulation pathways.
Why This Research Matters
Melanotan II occupies a foundational position in melanocortin peptide research. It served as both a research tool and a parent compound — its broad receptor activity profile enabled researchers to characterize the melanocortin receptor family, and its unexpected MC4R-mediated effects led directly to the development of PT-141. The compound illustrates how research tools designed for one purpose can generate discoveries in entirely different biological systems.
Explore More
Compound Research Kits
All information presented in this article references published research literature and is intended for educational purposes only. Research peptides are sold strictly for laboratory research use and are not approved for human consumption or medical treatment.